DRREDDY

Key Ratios / Metrics P/E ratio: 18–19x — moderate valuation vs. historical averages. Return on Equity (ROE): 18–19%, indicating decent profitability. Dividend yield: 0.6–0.7%, modest income return. Market cap: ₹1,03,000–₹1,04,000 cr. Interpretation: Valuation metrics show the business is not expensive relative to long-term earnings, but growth expectations are moderate and linked to product approvals, US generics pricing, and new launches (e.g., biosimilars, Semaglutide).